Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders' Equity

v3.20.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Balance at Dec. 31, 2018 $ 5,808,649 $ 3,125 $ 17,295,408 $ (11,489,884)
Balance, shares at Dec. 31, 2018   3,124,961    
Warrants exercised for cash 22,320 $ 9 22,311  
Warrants exercised for cash, shares   9,300    
Stock compensation expense 3,500   3,500  
Net loss (457,018)     (457,018)
Balance at Mar. 31, 2019 5,377,451 $ 3,134 17,321,219 (11,946,902)
Balance, shares at Mar. 31, 2019   3,134,261    
Stock compensation expense 3,431   3,431  
Net loss (450,503)     (450,503)
Balance at Jun. 30, 2019 4,930,379 $ 3,134 17,324,650 (12,397,405)
Balance, shares at Jun. 30, 2019   3,134,261    
Balance at Dec. 31, 2019 2,834,925 $ 3,134 17,326,553 (14,494,762)
Balance, shares at Dec. 31, 2019   3,134,261    
Stock compensation expense 128,847 $ 186 128,661  
Stock compensation expense, shares   186,000    
Net loss (551,094)     (551,094)
Balance at Mar. 31, 2020 2,412,678 $ 3,320 17,455,214 (15,045,856)
Balance, shares at Mar. 31, 2020   3,320,261    
Warrants exercised for cash 2,946,480 $ 1,228 2,945,252  
Warrants exercised for cash, shares   1,227,700    
Stock compensation expense 3,397   3,397  
Common stock issued for cash 1,250,000 $ 521 1,249,479  
Common stock issued for cash, Shares   520,838    
Net loss (437,968)     (437,968)
Balance at Jun. 30, 2020 $ 6,174,587 $ 5,069 $ 21,653,342 $ (15,483,824)
Balance, shares at Jun. 30, 2020   5,068,799